EP Staff Education Clinical Staff Ilyas Colombowala, MD, FACC, FHRS →
Patient library → ← Main site

Condition

Sinus Node Dysfunction (Sick Sinus Syndrome)

A spectrum of sinus node and atrial pathology producing inappropriate bradycardia, pauses, chronotropic incompetence, and often coexisting atrial tachyarrhythmias. The most common indication for permanent pacing in adults.

ECG features

  • ▸Inappropriate sinus bradycardia — sustained rate <50 bpm at rest without identifiable cause
  • ▸Sinus pauses or sinus arrest with junctional or ventricular escape
  • ▸Sinoatrial exit block — Mobitz I or II pattern in PP intervals
  • ▸Chronotropic incompetence — failure to reach 80% of age-predicted maximum on exercise
  • ▸Tachy-brady syndrome: alternating AF/flutter/AT with prolonged post-conversion pauses
  • ▸Atrial fibrillation with slow ventricular response in the absence of AV nodal blockers

Differential

  • ▸Drug-induced bradycardia (beta-blockers, calcium channel blockers, digoxin, amiodarone, ivabradine, clonidine)
  • ▸Hypothyroidism — always check TSH before pacing
  • ▸Inferior MI with sinus node ischemia (RCA territory)
  • ▸High vagal tone — athletes, sleep, vasovagal episodes
  • ▸Obstructive sleep apnea — nocturnal bradycardia and pauses
  • ▸Hypothermia, electrolyte disturbance, raised intracranial pressure

Anatomy and physiology

The sinus node is a 10–20 mm crescent of specialized pacemaker cells running along the lateral aspect of the SVC-RA junction near the crista terminalis. Its blood supply comes from the SA nodal artery, which arises from the RCA in ~60% of patients and the LCx in ~40%. Ischemic or infiltrative disease of this region drives much of SND.

Sinus node function depends on:

  • The funny current (If) carried by HCN channels — drives spontaneous diastolic depolarization
  • Calcium clock mechanism — local SR Ca²⁺ release contributes to automaticity
  • Autonomic balance — sympathetic input speeds the rate; parasympathetic slows it via the right vagus

Aging, fibrosis, ion channel dysfunction (SCN5A, HCN4 mutations), inflammation, and ischemia all converge on a final common phenotype of impaired automaticity and exit block.

Clinical phenotypes

SND is not one disease — it’s a constellation. Patients can express any combination:

  • Inappropriate sinus bradycardia: persistently slow rate not explained by fitness or medication
  • Sinus pauses and arrest: pauses >3 seconds while awake are concerning; >5 seconds usually pathologic; nocturnal pauses common in healthy individuals
  • SA exit block: the node fires but the impulse fails to exit. Looks like a “dropped” P wave with PP intervals that fit a mathematical pattern
  • Chronotropic incompetence: heart rate fails to rise appropriately with exertion. Confirmed on exercise testing — failure to achieve 80% of (220−age) or a slow ramp
  • Tachy-brady syndrome: AF, flutter, or AT alternating with brady. Post-conversion pause is the symptomatic moment. Driving the AV node with rate-control drugs aggravates the brady; not treating leaves the tachy
  • Atrial standstill: rare end-stage phenotype with no atrial activity, typically with junctional escape and slow VR

Work-up

  • 12-lead ECG in symptoms when possible
  • Ambulatory monitoring: Holter for daily symptoms, patch monitor for 14–30 days, implantable loop recorder for infrequent events. Symptom diary is essential — without symptom-rhythm correlation, you can’t justify a pacemaker
  • Exercise testing to assess chronotropic competence
  • Echocardiogram for structural disease
  • Labs: TSH, electrolytes, drug levels where relevant
  • Sleep study in any patient with predominantly nocturnal bradycardia or pauses
  • Medication review: beta-blockers, calcium channel blockers, digoxin, amiodarone, ivabradine, donepezil, lithium, clonidine

Drug-induced bradycardia

A huge fraction of “SND” referrals resolve when offending drugs are stopped. Common culprits:

  • Beta-blockers — especially when added without dose titration in older patients
  • Non-DHP calcium channel blockers — diltiazem, verapamil
  • Digoxin — bradycardia and AV block, especially with renal impairment
  • Amiodarone — sinus slowing common, dose-dependent
  • Ivabradine — pure sinus node inhibition; obviously slows the rate
  • Clonidine, dexmedetomidine — central sympatholysis
  • Combinations are additive — beta-blocker + diltiazem is a frequent offender

Many patients have true SND unmasked by these drugs — they only became symptomatic when started on rate control for AF. These patients will need both the device and the drug.

Pacing indications

Pacing is recommended when symptomatic bradycardia is documented and reversible causes have been addressed.

  • Class I: symptomatic SND with documented symptom-rhythm correlation; chronotropic incompetence with exertional symptoms; symptomatic bradycardia from required drug therapy with no alternative
  • Class IIa: syncope of unclear origin with EP-demonstrated abnormal sinus node function; heart rate <40 with mild symptoms
  • Not indicated: asymptomatic bradycardia, asymptomatic nocturnal pauses, sinus bradycardia in trained athletes

Device choice

  • Dual-chamber (DDD/DDDR) with managed ventricular pacing algorithms is the standard — preserves AV synchrony, reduces AF, minimizes RV pacing burden
  • Single-chamber atrial (AAI) is theoretically appealing but leaves the patient vulnerable to future AV block — rarely used today
  • Rate-responsive pacing (R) for chronotropic incompetence — accelerometer or minute-ventilation sensors
  • CRT if SND coexists with LV dysfunction and high anticipated ventricular pacing burden

Practical notes

  • Discharge teaching should emphasize symptom diaries — patients are often surprised when their fatigue or near-syncope improves with pacing
  • Tachy-brady patients can usually start or resume AV nodal blockers once paced — this is the main therapeutic gain
  • Pacemaker doesn’t prevent the AF — anticoagulate as for AF independent of device

Watch

Short videos to help illustrate this topic. Embedded from the original channels — content belongs to them.

Video pending Add a youtube video ID to display: Sinus node anatomy and the brady-tachy spectrum
Sinus node anatomy and the brady-tachy spectrum · EP educational channel · Reviews SA node blood supply and the pathophysiology of tachy-brady syndrome.

Last reviewed by Dr. Colombowala on May 22, 2026.

Not medical advice. This page is educational. Your situation may differ — discuss it with Dr. Colombowala or your treating physician before making decisions.